Authors
Loading...
Meta-analysis finds antiplatelet agents reduce thrombosis risk in arteriovenous fistulae but not grafts, highlighting targeted use for hemodialysis vascular access.
Coleman et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: